Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-054876
Filing Date
2006-03-15
Accepted
2006-03-15 14:56:44
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE PERIOD ENDED DECEMBER 31, 2005 d10k.htm 10-K 1523280
2 CODE OF ETHICS dex14.htm EX-14 78620
3 SUBSIDIARIES OF THE REGISTRANT dex21.htm EX-21 13067
4 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9449
5 SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9496
6 SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 3462
7 SECTION 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 3657
8 GRAPHIC g51294image002.jpg GRAPHIC 2726
  Complete submission text file 0001193125-06-054876.txt   1646366
Mailing Address
Business Address 16825 NORTHCHASE DR STE 1300 HOUSTON TX 77060 2818732674
US ONCOLOGY INC (Filer) CIK: 0000943061 (see all company filings)

EIN.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26190 | Film No.: 06687901
SIC: 8093 Services-Specialty Outpatient Facilities, NEC